BR9708468A - Tratamento de fotoferese de leucocitos. - Google Patents

Tratamento de fotoferese de leucocitos.

Info

Publication number
BR9708468A
BR9708468A BR9708468-9A BR9708468A BR9708468A BR 9708468 A BR9708468 A BR 9708468A BR 9708468 A BR9708468 A BR 9708468A BR 9708468 A BR9708468 A BR 9708468A
Authority
BR
Brazil
Prior art keywords
treatment
photopheresis
leukocyte
patient
disclosed
Prior art date
Application number
BR9708468-9A
Other languages
English (en)
Inventor
Susan N Mclaughlin
Bruce C Stouch
Jerome B Zeldis
Original Assignee
Therakos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therakos Inc filed Critical Therakos Inc
Publication of BR9708468A publication Critical patent/BR9708468A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0066Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Anesthesiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"TRATAMENTO DE FOTOFERESE DE LEUCóCITOS"<D>. é revelado um processo para tratar infecções de células sang³íneas mononucleares, que não infecções retroviróticas. é também um processo para modular a função de monócitos. O processo envolve o tratamento do sangue do paciente com um composto fotoativável seguido por ativação de luz ultravioleta do composto fotoativável. O sangue tratado como tal é retornado para o paciente em um processo conhecido como fotoferese extracorpórea. A função do monócito é modulada por este tratamento.
BR9708468-9A 1996-03-29 1997-03-26 Tratamento de fotoferese de leucocitos. BR9708468A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1426996P 1996-03-29 1996-03-29
US2989396P 1996-11-08 1996-11-08
PCT/US1997/004772 WO1997036581A1 (en) 1996-03-29 1997-03-26 Photopheresis treatment of leukocytes

Publications (1)

Publication Number Publication Date
BR9708468A true BR9708468A (pt) 2000-01-04

Family

ID=26685876

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708468-9A BR9708468A (pt) 1996-03-29 1997-03-26 Tratamento de fotoferese de leucocitos.

Country Status (11)

Country Link
US (1) US5984887A (pt)
EP (1) EP0935462B1 (pt)
JP (1) JP2000510101A (pt)
CN (1) CN1121217C (pt)
AT (1) ATE300298T1 (pt)
AU (1) AU710242B2 (pt)
BR (1) BR9708468A (pt)
CA (1) CA2250919C (pt)
DE (1) DE69733826T2 (pt)
IL (1) IL126366A (pt)
WO (1) WO1997036581A1 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU717624B2 (en) * 1996-03-29 2000-03-30 Therakos, Inc. Photopheresis treatment of chronic HCV infections
ES2265664T3 (es) * 1997-07-10 2007-02-16 Therakos, Inc. Tratamiento de enfermedades inflamatorias del intestino o de la vejiga urinaria.
HUP0004238A3 (en) * 1997-11-28 2001-07-30 Lg Chemical Ltd Imidazole derivatives having an inhibitory activity for farnesyl transferase, process for preparation thereof and pharmaceutical compositions containing them
US7611831B2 (en) 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
US6219584B1 (en) 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US8722422B2 (en) 1999-09-03 2014-05-13 Therakos, Inc. Uninterrupted flow pump apparatus and method
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
WO2001024824A1 (en) * 1999-10-05 2001-04-12 Universite De Montreal Rhodamine derivatives for photodynamic diagnosis and treatment
AU2001253688A1 (en) * 2000-04-19 2001-11-07 Clemson University Uvc radiation therapy for chronic lymphocytic leukemia
US6970740B2 (en) * 2000-04-19 2005-11-29 Clemson University UVC rediation therapy for leukemia
US6793643B1 (en) 2000-04-21 2004-09-21 Therakos, Inc. Low extracorporeal volume treatment system
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US20030157073A1 (en) * 2001-11-29 2003-08-21 Peritt David L. Methods for pretreating a subject with apoptotic cells
US7479123B2 (en) * 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
US20040127840A1 (en) 2002-03-04 2004-07-01 Steve Gara Blood separation apparatus and method of using the same
US7186230B2 (en) * 2002-03-04 2007-03-06 Therakos, Inc Method and apparatus for the continuous separation of biological fluids into components
CA2377442A1 (en) * 2002-03-20 2003-09-20 Thomas Ichim Increasing tumor oxygen content by administration of stressed cells
US9169461B2 (en) * 2005-11-02 2015-10-27 Therakos, Inc. Use of apoptotic cells ex vivo to generate regulatory T cells
CN101484586A (zh) 2006-05-02 2009-07-15 特拉科斯有限公司 检测移植物抗宿主疾病易感性或移植相关死亡率的方法和试剂
EP2019590A4 (en) * 2006-05-03 2011-08-03 Therakos Inc METHODS FOR TREATING DISEASES INVOLVING STRESS-RELATED CONDITIONS AND CONDITIONS
JP2010519955A (ja) * 2007-03-01 2010-06-10 ナノスペクトラ、バイオサイアンセズ、インク 循環する細胞の体外アブレーションのためのデバイスおよび方法
US9358292B2 (en) 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
WO2015195896A1 (en) 2014-06-19 2015-12-23 Immunolight, Llc Methods and systems for treating cell proliferation disorders with psoralen derivatives
CA3095369C (en) 2008-04-04 2023-09-26 Immunolight, Llc Non-invasive systems and methods for in-situ photobiomodulation
US20100210989A1 (en) 2008-12-23 2010-08-19 Janet Lesley Macpherson Processing blood
US9399093B2 (en) 2012-01-27 2016-07-26 Fenwal, Inc. Systems and methods for performing online extracorporeal photopheresis
US20130252227A1 (en) 2012-03-20 2013-09-26 Fenwal, Inc. Apparatus and Method for Providing Cryopreserved ECP-Treated Mononuclear Cells
US11571504B2 (en) 2019-03-21 2023-02-07 Fenwal, Inc. Apparatus and method for batch photoactivation of mononuclear cells
US20150071935A1 (en) * 2012-05-27 2015-03-12 Marv Enterprises, LLC Treatment for the rapid amelioration of clinical depression
US10172995B2 (en) 2013-02-06 2019-01-08 Fenwal, Inc. System and method for determining irradiation exposure time with irradiation sensors during extracorporeal photopheresis
WO2014123521A1 (en) * 2013-02-06 2014-08-14 Fenwal, Inc. Method for delivering desired light dose to cells in a light attenuating medium
EP3097108B8 (en) 2014-01-23 2021-04-07 Immunolight, LLC Use of psoralen derivatives and combination therapy for treatment of cell proliferation disorders
US9208296B1 (en) 2014-06-19 2015-12-08 Norman Romanick Prevention of use of a contaminated medical product
US10434240B2 (en) 2015-08-17 2019-10-08 Fenwal, Inc. Methods and systems for processing and washing a photopheresis mononuclear cell product
EP3372259B1 (en) 2017-03-07 2022-11-23 Fenwal, Inc. System and methods for separating blood under conditions of reduced plasma clarity
US20190099610A1 (en) * 2017-10-04 2019-04-04 Hyper Light Technologies, Llc Cancer cell treatment
US11318239B2 (en) 2018-03-01 2022-05-03 Fenwal, Inc. Systems and methods for performing online extracorporeal photopheresis
CA3100050A1 (en) 2018-05-11 2019-11-14 Lupagen, Inc. Systems and methods for closed loop, real-time modifications of patient cells
AU2020404121A1 (en) 2019-12-20 2022-06-23 Mallinckrodt Pharmaceuticals Ireland Limited Method for generating immunoregulatory cells in a blood-derived sample
WO2024134596A1 (en) 2022-12-21 2024-06-27 Mallinckrodt Pharmaceuticals Ireland Limited Adiponectin alone or in combination with extracorporeal photopheresis (ecp) for immune related adverse events of immune checkpoint inhibitors
EP4389122A1 (en) 2022-12-21 2024-06-26 Mallinckrodt Pharmaceuticals Ireland Limited Adiponectin alone or in combination with extracorporeal photopheresis (ecp) for immune related adverse events of immune checkpoint inhibitors

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US298279A (en) 1884-05-06 Edwaed w
US549030A (en) * 1895-10-29 Vehicle-spring
US299953A (en) 1884-06-10 Ealph bbownson
US298567A (en) 1884-05-13 Claek fishes
US4196281A (en) * 1976-10-20 1980-04-01 Regents Of The University Of California Psoralens
IT1088554B (it) * 1977-11-17 1985-06-10 F I D I A Spa Procedimento sellettivo per la preparazione di derivati della 7-indrossi cumarina
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
US4428744A (en) * 1979-12-11 1984-01-31 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4398906A (en) * 1979-12-11 1983-08-16 Frederic A. Bourke, Jr. Method for externally treating the blood
US4464166A (en) * 1981-06-12 1984-08-07 Frederic A. Bourke, Jr. Method for externally treating the blood
US4612007A (en) * 1981-06-16 1986-09-16 Edelson Richard Leslie Method and system for externally treating the blood
FR2521999B1 (fr) * 1982-02-25 1984-05-25 Inst Nat Sante Rech Med Pyrido (3',4' : 4,5) furo (3,2-g) coumarines ou pyrido (3,4-h) psoralenes, obtention, applications en cosmetologie et a titre de medicaments, et compositions cosmetiques et pharmaceutiques les contenant
FR2521998B1 (fr) * 1982-02-25 1985-10-25 Inst Nat Sante Rech Med Pyrido (3,4-c) psoralenes, obtention, applications en cosmetologie et a titre de medicaments et compositions cosmetiques et pharmaceutiques les contenant
US4613322A (en) * 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4683889A (en) * 1983-03-29 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US5176921A (en) * 1983-05-02 1993-01-05 Diamond Scientific Co. Method of blood component decontamination by glucose addition
US4693981A (en) * 1983-12-20 1987-09-15 Advanced Genetics Research Institute Preparation of inactivated viral vaccines
US4705498A (en) * 1984-10-29 1987-11-10 Mcneilab, Inc. Disposable temperature probe for photoactivation patient treatment system
US4578056A (en) * 1984-10-29 1986-03-25 Extracorporeal Medical Specialties, Inc. Patient photopheresis treatment apparatus and method
US4681568A (en) * 1984-10-29 1987-07-21 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4573960A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Three phase irradiation treatment process
US4568328A (en) * 1984-10-29 1986-02-04 Extracorporeal Medical Specialties, Inc. Automated photophoresis blood portion control methods and apparatus
US4687464A (en) * 1984-10-29 1987-08-18 Mcneilab, Inc. Zero insertion force socket for photoactivation patient treatment system
US4623328A (en) * 1984-10-29 1986-11-18 Mcneilab, Inc. Pump monitor for photoactivation patient treatment system
US4692138A (en) * 1984-10-29 1987-09-08 Mcneilab, Inc. Pump block for interfacing irradiation chamber to photoactivation patient treatment system
US4596547A (en) * 1984-10-29 1986-06-24 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4573962A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Cassette drawer assembly for photoactivation patient treatment system
US4573961A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Electronic control methods for puvapheresis apparatus
US4737140A (en) * 1984-10-29 1988-04-12 Mcneilab, Inc. Irradiation chamber for photoactivation patient treatment system
US4708715A (en) * 1984-10-29 1987-11-24 Mcneilab, Inc. Light array assembly for photoactivation patient treatment system
US4643710A (en) * 1984-10-29 1987-02-17 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4897789A (en) * 1986-02-27 1990-01-30 Mcneilab, Inc. Electronic device for authenticating and verifying disposable elements
USD298567S (en) * 1986-02-27 1988-11-15 Mcneilab, Inc. Flexible patient fluid container
USD299953S (en) * 1986-02-27 1989-02-21 Mcneilab, Inc. Control panel for a patient photophoresis treatment unit
USD298279S (en) * 1986-02-27 1988-10-25 Mcneilab, Inc. Disposable patient fluid irradiation chamber
USD299531S (en) * 1986-02-27 1989-01-24 Mcneilab, Inc. Patient photopheresis treatment unit
US4726949A (en) * 1986-08-26 1988-02-23 Baxter Travenol Laboratories, Inc. Irradiation of blood products
US4952812A (en) * 1986-08-26 1990-08-28 Baxter International Inc. Irradiation of blood products
US4866282A (en) * 1986-08-26 1989-09-12 Baxter International Inc. Irradiation of blood products
US4838852A (en) * 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US4960408A (en) * 1989-01-10 1990-10-02 Klainer Albert S Treatment methods and vaccines for stimulating an immunological response against retroviruses
US5356929A (en) * 1989-01-23 1994-10-18 Lehigh University Reduced and quaternized psoralens as photo-activated therapeutics
US5216176A (en) * 1989-01-23 1993-06-01 Lehigh University 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor
US4921473A (en) * 1989-02-02 1990-05-01 Therakos, Inc. Multicomponent fluid separation and irradiation system
US4999375A (en) * 1989-04-11 1991-03-12 Hoffmann-La Roche Inc. Psoralen reagent compositions for extracorporeal treatment of blood
CA2089005C (en) * 1991-06-21 1999-01-19 John Chapman Method for inactivating pathogens in a body fluid
WO1993014791A2 (en) * 1992-01-27 1993-08-05 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5459030A (en) * 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
ATE192898T1 (de) * 1992-08-07 2000-06-15 Cerus Corp Verfahren zur inaktivierung von bakterien in blutpräparaten mit hilfe von methoxypsoralen
US5651993A (en) * 1992-11-18 1997-07-29 Yale University Specific immune system modulation
US5820872A (en) * 1992-11-18 1998-10-13 Yale University Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
WO1997021346A1 (en) * 1995-12-14 1997-06-19 Cerus Corporation Inactivation of non-enveloped virus
AU717624B2 (en) * 1996-03-29 2000-03-30 Therakos, Inc. Photopheresis treatment of chronic HCV infections
AU2453697A (en) * 1996-04-10 1997-10-29 Trustees Of The University Of Pennsylvania, The Use of photopheresis in the treatment of chronic infection by hepatitis c virus

Also Published As

Publication number Publication date
IL126366A0 (en) 1999-05-09
DE69733826D1 (de) 2005-09-01
DE69733826T2 (de) 2006-05-24
JP2000510101A (ja) 2000-08-08
IL126366A (en) 2011-10-31
EP0935462B1 (en) 2005-07-27
ATE300298T1 (de) 2005-08-15
WO1997036581A1 (en) 1997-10-09
CN1121217C (zh) 2003-09-17
CA2250919C (en) 2008-05-13
CA2250919A1 (en) 1997-10-09
AU710242B2 (en) 1999-09-16
AU2422897A (en) 1997-10-22
CN1214630A (zh) 1999-04-21
EP0935462A1 (en) 1999-08-18
EP0935462A4 (en) 2001-04-18
US5984887A (en) 1999-11-16

Similar Documents

Publication Publication Date Title
BR9708468A (pt) Tratamento de fotoferese de leucocitos.
AU1373499A (en) Use of 9-deoxy-2&#39;, 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1&#39;,3&#39;-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
AU6951087A (en) Pump block for interfacing irradiation chamber to photoactivation patient treatment system
DE69129800D1 (de) Behandlung von menschlichen retrovirus-infektionen mit 2&#39;,3&#39;-dideoxyinosin
AU4992985A (en) Method and system for removing immunosuppressive components from the blood of mammals
MY113490A (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
DE69834724D1 (de) Behandlung von Darm- oder Blasenentzündungen
BR9708406A (pt) Tratamento por fotoferese de infecções crÈnicas por hcv.
MX9303127A (es) Metodo para reducir selectivamente la poblacion celular de leucocitos.
DE69626650D1 (de) Verwendung von aminoadamantan-verbindungen als immunregulatoren
AU4312093A (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
AU6950487A (en) Irradiation chamber for photoactivation patient treatment system
WO1991018992A3 (en) Methods to make and use proteinaceous material present in kinin-free high molecular weight kininogen
RU97111211A (ru) Способ лечения больных с хирургическим эндотоксикозом
RU95105874A (ru) Способ лечения острых тромбозов глубоких вен нижних конечностей
SU936512A1 (ru) Способ предотвращения свертывания крови
IT1248592B (it) Detossificazione delle acque di vegetazione
RU95116161A (ru) Способ лечения синдрома диссеминированного внутрисосудистого микротромбоза при тяжелой изолированной и сочетанной черепно-мозговой травме
AU6661394A (en) Purification of fluoronucleosides
RU92016457A (ru) Антикоагулирующий препарат

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal